Invited Lectures

  1. Osaka University & affiliates, Osaka, Japan (December 2017)
  2. Sanders Tri-Institutional Chemical Biology Seminar Series: New York, NY (September 2017)
  3. Gordon Research Conference: Stowe, VT (July 2017)
  4. Gordon Research Conference: Mount Snow, VT (June 2017)
  5. AstraZeneca: 2017 Biohub Seminar Series, Waltham, MA (May 2017)
  6. National Cancer Institute: 2017 RNA Biology Symposium, Washington, DC (April 2017)
  7. American Chemical Society: 253rd National Meeting, San Francisco, CA (April 2017)
  8. SAB/CAB Sigma RNA Symposium, Albany, NY (March 2017)
  9. University of Michigan, Ann Arbor, MI (March 2017)
  10. Iowa State University, Ames, IA (March 2017)
  11. University of Illinois, Urbana, IL (February 2017)
  12. BNY Mellon Wealth Management, Ft. Lauderdale (January 2017)
  13. ACS Webinar-Rational Design of Small Molecules Targeting RNA.
  14. 1st International Conference on Biomolecular Systems Research, Berlin, Germany (November 2016)
  15. BMS/Scripps Symposium, Pennington, NJ (September 2016)
  16. Tau Consortium Investigator’s Meeting, Denver, CO (August 2016)
  17. 17th Tetrahedron Symposium, Barcelona, Spain, (June/July 2016)
  18. World Preclinical Congress, Boston, MA (June 2016)
  19. Jude’s Children’s Research Hospital, Memphis, TN (May 2016)
  20. Denali Therapeutics, San Francisco, CA (April 2016)
  21. Target ALS Foundation Annual Meeting, New York, NY (April 2016)
  22. BMS Chemistry Symposium, Pennington, NJ (April 2016)
  23. SAB/CAB Sigma RNA Symposium, Albany, NY (March 2016)
  24. University of Colorado, Boulder, CO (February 2016)
  25. Columbia University, New York, NY (January 2016)
  26. Tau Consortium Investigator’s Meeting, Worth, TX (January 2016)
  27. Biogen, Boston, MA (January 2016)
  28. NIH High Risk – High Reward Symposium (December 2015)
  29. University of Florida, Gainesville, FL (December 2015)
  30. RNA Day at GSK, Philadelphia, PA (November 2015)
  31. Pfizer, Boston, MA (November 2015)
  32. 16th International Conference on Alzheimer’s Drug Discovery, Jersey City, NJ (October 2015)
  33. University of New Mexico, Albuquerque, NM (September 2015)
  34. 2015 Annual MDF Conference, Washington, DC (September 2015)
  35. Annual Blavatnik Science Symposium, New York, NY (August 2015)
  36. Tau Consortium Investigator’s Meeting, San Francisco, CA (July 2015)
  37. GRC Conference, Newport, RI (June/July 2015)
  38. GRC Conference, New London, NH, (June 2015)
  39. High Throughput Screening Gordon Research Conference (June 2015)
  40. Nucleosides and nucleotide Gordon Research Conference (June 2015)
  41. Target ALS Meeting, New York, NY (April 2015)
  42. Department of Chemistry, University of Chicago (April 2015)
  43. 249th ACS National Meeting & Exposition in Denver, CO (March 2015)
  44. Packard Center Johns Hopkins University Medical Center, Baltimore, MD (March 2015)
  45. AstraZeneca Neuroscience Cambridge, MA (March 2015)
  46. Molecular Biophysics Training Program (MBTP), University of California, San Diego (February 2015)
  47. ChEM-H (Chemistry, Engineering & Medicine for Human Health), Stanford University (February 2015)
  48. Novartis Emeryville, CA (February 2015)
  49. Department of Chemistry University of Alabama-Birmingham (February 2015)
  50. Tau Consortium Investigator’s Fort Worth Texas (January 2015)
  51. University of Florida, Gainesville Brainstorming DM1 (December 2014)
  52. ALS-TDI 10th Annual Leadership Summit  Boston, MA (November 2014)
  53. Bristol Myers Squibb, Wallingford, CT (November 2015)
  54. Keynote speaker at NY CAP Research University at Albany, Albany Medical College and Rensselaer Polytechnic Institute. (October 2014)
  55. Boehringer Ridgefield, CT.  (October 2014)
  56. Myotonic Dystrophy  Foundation National Meeting and Washington, DC (September 2014)
  57. 248th  ACS  National Division  of  Organic  Chemistry.  Chemical  Approaches  Toward Understanding and Reprogramming RNA. San Francisco, CA (August 2014)
  58. 248th  ACS  National Division  of  Medicinal  Chemistry  Awards  Symposium.  San Francisco, CA (August 2014)
  59. Tau Consortium 9, Rainwater Foundation, San Francisco, CA (July 2014)
  60. Post-transcriptional Gene Regulation Gordon Research Conference, Salve Regina (July 2014)
  61. Pfizer pharmaceuticals, Cambridge, MA (June 2014)
  62. Vertex pharmaceuticals, Boston MA (June 2014)
  63. AstraZeneca symposium visit to Scripps Florida (June 2014)
  64. Recent Advances in Chemical Biology, University of (May 2014)
  65. Scripps Research Institute, Scripps  Novartis Lectureship in Chemical Biology Seminar Series in honor of Ron Breaker (Yale).  (May 2014)
  66. Target ALS Consortium New York, NY (April 2014)
  67. Merck, Rahway, NJ (April 2014)
  68. Cydan, Cambridge MA (April 2014)
  69. 247th  ACS  National  Meeting,  Dallas,  TX  “Using  peptidomimetics  to  design  potent,  modularly assembled compounds targeting RNA” (March 2014)
  70. 247th ACS National Meeting, Dallas, TX “Rational design of small molecules targeting repeating transcripts”” (March 2014)
  71. Bristol Myers Squibb, Wallingford, (February 2014)
  72. The Scripps Research Institute, Department of LaJolla, CA (January 2014)
  73. Society for Laboratory Automation & Screening (SLAS), SLAS Innovation Award Finalist – San Diego, CA (January 2014)
  74. Tau Consortium Investigator’s Meeting Fort Worth, TX (January 2014)
  75. AstraZeneca Mölndal Sweden (December 2013)
  76. NIGMS Workshop on RNA Structure, Function, and Bethesda, MD (November 2013)
  77. Conquer Huntington’s Disease Initiative (CHDI) RNA workshop Princeton, NJ (November 2013)
  78. Biomarin – video presentation (November 2013)
  79. FIBER Forum, Kobe, Japan (November 2013)
  80. International Nucleic Acids Symposium, Yokohama, Japan (November 2013)
  81. RNA Metabolism  in  Neurological  Disease,  8th   Brain  Research  Conference,  San  Diego,  CA (November 2013)
  82. Symposium on RNA Biology X: RNA Tool & Target, UNC Chapel Hill (October 2013)
  83. Novartis, Cambridge, MA (October 2013)
  84. FRAXA Investigators Meeting, Southbridge, MA (September 2013)
  85. 243rd ACS National Meeting, Indianapolis, IN; Eli Lilly Award in Biological Chemistry: “Rational Design of Small Molecules Targeting RNA” (September 2013)
  86. Genzyme Corporation, Cambridge, MA (June 2013)
  87. 2013 Muscular  Dystrophy  Association  (MDA)  Scientific  Conference,  Washington,  DC  (April 2013)
  88. 2013 Winter/Spring  Pharmacology  Program  Research  Seminar  Course,  Weill  Cornell  Medical College, NY (April 2013)
  89. Novartis, Cambridge, MA (March 2013)
  90. Max Planck Florida Institute for Neuroscience, South Florida Academic Leadership Symposium, Jupiter, FL (March 2013)
  91. Isis Pharmaceuticals, Carlsbad, CA (February 2013)
  92. 2013 Frontiers in Biomedical Research Symposium, Indian Wells, CA (February 2013)
  93. Tau Consortium Meeting, New York City, NY (January 2013)
  94. University of Florida, Department of Molecular Genetics & Microbiology (November 2012)
  95. 2012 RiboClub  –  New  Frontiers  of  RNA  Biology,  Diagnostics  and  Therapeutics,  Quebec, Canada (September 2012)
  96. Workshop on Alzheimer’s Disease and Related Disorders, Helena, CA (July/August 2012)
  97. 7th  International  Conference  on  Unstable  Microsatellites  and  Human  Disease,  Strasbourg, France: “Rational Design of Small Molecules Targeting Repeating Transcripts” (June 2012)
  98. University of Massachusetts Medical School, Department of Biochemistry (April 2012)
  99. 243rd ACS National Meeting, San Diego, CA; David Gin New Investigator Award: “Rational Design of Small Molecules Targeting RNA” (March 2012)
  100. Broad  Institute,   Chemical   Biology   Program,   Cambridge,   MA:   “Rational   Design   of   Small Molecules Targeting RNA” (March 2012)
  101. University of  Minnesota,  Department  of  Chemistry  –  “Rational  Design  of  Small  Molecules Targeting RNA” (February 2012)
  102. SomaLogic, Boulder, CO : “Rational Design of Small Molecules Targeting RNA” (January 2012)
  103. UF-Clearwater; IDMC-8-001  –  8th     Myotonic  Dystrophy  Consortium:  “Rational  Design  of Small Molecules Targeting RNA” (December 2011)
  104. CHDI Meeting, New York City, NY (November 2011)
  105. Florida Atlantic University, Medical School (October 2011)
  106. The RNA  Institute,  University  of  Albany,  Albany,  NY:  “Rational  Design  of  Small  Molecules Targeting RNA” (October 2011)
  107. CHDI Foundation,  New  York,  NY:  “Rational  Design  of  Small  Molecules  Targeting  RNA” (September 2011)
  108. RNA World to the Clinic, Washington, DC (September 2010)
  109. Marigold  Foundation   Therapeutic   Strategies   for   Myotonic   Dystrophy   Workshop,   Calgary, Canada (September 2010)
  110. University of North Carolina, Chapel Hill (October 2009)
  111. Scripps Florida, Department of Chemistry (October 2009)
  112. Pennsylvania State University, Department of Chemistry (December 2008)
  113. National Research  Council  Canada  (NRC),  Steacie  Institute  for  Molecular  Sciences,  Ottawa, Canada (March 2008)
  114. 235th  National  ACS  Meeting,  New  Orleans,  LA:  “Selecting  RNA  Loop-Ligand  Interactions  via Microarray” (April 2008)
  115. University of Maryland, College Park, Bioscience Research Day: “Progress Toward a Chemical Code for Recognition of RNA” (December 2007)
  116. 234th National ACS Meeting, Boston, MA: “Progress Towards a Chemical Code for Recognition of RNA” (August 2007)
  117. NIGMS Sponsored    Workshop,     Bethesda,    MD:    “Expanding    the    Chemical     Space    for Carbohydrates: Synthetic Strategies, High Throughput Technologies & Standards” (April 2007)
  118. 233rd National ACS Meeting, Chicago, IL: “Progress Towards a Chemical Code For Targeting RNA”, Carbohydrate Division (March 2007)
  119. Buffalo State University, Department of Chemistry (February 2007)
  120. Canisius College, Department of Chemistry & Biochemistry (January 2007)
  121. SUNY Fredonia, Department of Chemistry (December 2006)
  122. University of Rochester, Harrison Howe Chemical Biology Symposium (October 2006)
  123. Roswell Park Cancer Institute, Department of Biochemistry and Biophysics (September 2006)
  124. Rochester Institute of Technology, Department of Chemistry (2006)
  125. Roswell Park Cancer Institute, Department of Cellular and Molecular Biology (2006)
  126. SUNY Brockport, Department of Chemistry (2006)
  127. Indiana University, Department of Chemistry (2005)
  128. Johns Hopkins University, Department of Pharmacology (2005)
  129. University at Buffalo, Department of Chemistry (2005)
  130. Cornell University, Department of Chemistry (2005)
  131. University of Pennsylvania, Department of Chemistry (2005)
  132. Tufts University, Department of Chemistry (2005)
  133. University of Florida, Department of Medicinal Chemistry (2005)
  134. RNA Tools & Targets, San Diego, CA (2004)
  135. University of Alberta, Edmonton, Canada, Department of Chemistry (2004)